I have yet to see the Intellectual Property Appellate Board's verdict on the patent application for Novartis' cancer drug Glivec. But I did read Shamnad Basheer's post on spicyip to know that it has rejected Novartis' claim for a product patent on the drug famously dubbed the "magic bullet" against some cancers by Time magazine in 2001. Shamnad has done a great … Continue reading Glivec patent dispute : Bullet misses the mark
Apothecurry 